Valeant Pharmaceuticals InternationalInc said it would release preliminaryfourth-quarter results on March 15, followed by a conferencecall on the same day.

The Canadian drugmaker, in an announcement last week thatChief Executive Michael Pearson would return from medical leave,said it would also delay releasing its results, which had beenscheduled for Feb. 29.

"February 29th was my first day back to work following atwo-month medical absence," Pearson said in a statement onMonday. "Now that I have returned, I have been workingdiligently to review the business so that I can share our latestperformance and outlook with shareholders." (Reporting by Ankur Banerjee in Bengaluru; Editing by Ted Kerr)